Aceso Life Science Group Limited (0474.HK)

HKD 0.05

(0.0%)

Annual Income Statements

(In HKD)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 11 Million 312 Million 315 Million 346 Million 295.64 Million 319.51 Million
Cost of Revenue 111 Million 171 Million 153 Million 133 Million 129.04 Million 166.17 Million
Gross Profit -100 Million 141 Million 162 Million 213 Million 166.59 Million 153.33 Million
Operating Expenses 117 Million 125 Million 152 Million 197 Million 188.4 Million 215.08 Million
Selling, General and Administrative Expenses 124 Million 123 Million 146 Million 155 Million 188.52 Million 219.48 Million
Research and Development Expenses - -0.01 -1.37 -1.54 -0.83 -
Other Expenses 53 Million 69 Million 35 Million 59 Million -187.55 Million 5.13 Million
Cost and Expenses 228 Million 296 Million 305 Million 330 Million 317.45 Million 381.26 Million
Operating Income -224 Million -153 Million 10 Million 16 Million -21.81 Million -61.74 Million
Interest Expense 143 Million 140 Million 154 Million 191 Million 183.22 Million 141.43 Million
Income Tax Expense -14 Million -5 Million 41 Million 25 Million 10.51 Million -63.94 Million
Earnings before Tax -823 Million -213 Million -555 Million -323 Million -267.22 Million -480.57 Million
Net Income -462 Million -264 Million -370 Million -376 Million -283.71 Million -380.87 Million
Earnings Per Share Basic -0.06 -0.04 -0.05 -0.06 -0.05 -0.08
Earnings Per Share Diluted -0.06 -0.04 -0.05 -0.05 -0.05 -0.08
Weighted Average Shares Outstanding 7.27 Billion 7.31 Billion 7.2 Billion 6.55 Billion 5.77 Billion 4.93 Billion
Weighted Average Shares Outstanding (Diluted) 7.27 Billion 7.31 Billion 7.43 Billion 7.01 Billion 5.77 Billion 4.93 Billion
Gross Margin -9.09 0.45 0.51 0.62 0.56 0.48
EBIT Margin -20.00 -0.32 0.49 1.37 -0.14 0.20
Profit Margin -42.00 -0.85 -1.17 -1.09 -0.96 -1.19
EBITDA -220 Million -21 Million -359 Million -69 Million -52.36 Million -280.78 Million
Earnings Before Tax Margin -20.36 -0.49 0.03 0.05 -0.07 -0.19

Income Statement Charts